HOPE FUNDS FOR CANCER RESEARCH
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$1,066,538
Cash & Equivalents
96%
Receivables (Non-Related)
3%
Prepaid Expenses
<1%
Related-Party Receivables
0%
Inventories
0%
Investments
0%
Property, Plant, & Equipment (net)
0%
Other Assets
0%
Liabilities in 2024 (Year End)
$438,500
Grants Payable
71%
Deferred Revenue
29%
Payables & Accruals
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$993,574
$1,022,381
+3%
Receivables (Non-Related)
$5,841
$37,328
+539%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$31,664
$6,829
-78%
Investments
-
-
-
Property, Plant, & Equipment (net)
-
-
-
Other Assets
-
-
-
Total Assets
$1,031,079
$1,066,538
+3%
Liabilities
2023
2024
Change
Payables & Accruals
-
-
-
Grants Payable
$399,799
$311,500
-22%
Deferred Revenue
-
$127,000
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$399,799
$438,500
+10%
Net assets
2023
2024
Change
Restricted Net Assets
-
-
-
Unrestricted Net Assets
$631,280
$628,038
-1%
Net assets
2023
2024
Change
Net assets
+$631,280
+$628,038
-1%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)